Defensin-chemokine heteromeric complexes derived from heterocellular activation-a possible target to inhibit CCL5 in cardiovascular settings
Ann Transl Med
.
2016 Dec;4(24):497.
doi: 10.21037/atm.2016.11.46.
Authors
Osamu Baba
1
,
Yongjian Liu
2
,
Gwendalyn J Randolph
1
Affiliations
1
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
2
Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
PMID:
28149859
PMCID:
PMC5233518
DOI:
10.21037/atm.2016.11.46
No abstract available
Publication types
Editorial
Comment
Grants and funding
R01 HL125655/HL/NHLBI NIH HHS/United States